Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium Workshop

被引：2

作者：

Kahl, Brad S. ^{[1
]}

Gordon, Leo I. ^{[2
,3
]}

Dreyling, Martin ^{[4
]}

Gascoyne, Randy D. ^{[5
]}

Sotomayor, Eduardo M. ^{[6
]}

机构：

[1] Univ Wisconsin, Madison, WI 53705 USA

[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

[4] Univ Munich Grosshadern, Munich, Germany

[5] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada

[6] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

来源：

LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 09期

关键词：

Lymphoma and Hodgkin's disease; immunotherapy; pharmacotherapeutics; marrow and stem cell transplantation clinical results; CHROMATIN STATE; EUROPEAN GROUP; PHASE-II; TRANSPLANTATION; LENALIDOMIDE; MULTICENTER; INHIBITION; BORTEZOMIB; MUTATIONS; LANDSCAPE;

D O I：

10.3109/10428194.2015.1045903

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin lymphoma characterized by the t(11; 14) chromosomal translocation and cyclin D1 over-expression. A biologically and clinically heterogeneous lymphoma, MCL, remains clinically challenging, with no proven curative therapy and no established standard of care. However, there have been considerable advances in the last several years in the treatment and understanding of MCL with the FDA approval of lenalidomide and ibrutinib, the development of other potentially active novel agents and the identification of recurrent mutations through new genomic sequencing approaches that may contribute to the biology of MCL and to therapeutic resistance. At the Lymphoma Research Foundation's 11th MCL Workshop, researchers gathered to discuss recent studies and current issues related to the biology of MCL, novel therapeutic targets and new treatment strategies. The presentations are summarized in this manuscript, which is intended to highlight areas of active investigation and identify topics for future research.

引用

页码：2505 / 2511

页数：7

共 49 条

[1] The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis [J].

Barsyte-Lovejoy, Dalia ;

Lau, Suzanne K. ;

Boutros, Paul C. ;

Khosravi, Fereshteh ;

Jurisica, Igor ;

Andrulis, Irene L. ;

Tsao, Ming S. ;

Penn, Linda Z. .

CANCER RESEARCH, 2006, 66 (10) :5330-5337

[2] Targeting malignant B cells with an immunotoxin against ROR1 [J].

Baskar, Sivasubramanian ;

Wiestner, Adrian ;

Wilson, Wyndham H. ;

Pastan, Ira ;

Rader, Christoph .

MABS, 2012, 4 (03) :349-361

[3] A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display [J].

Baskar, Sivasubramanian ;

Suschak, Jessica M. ;

Samija, Ivan ;

Srinivasan, Ramaprasad ;

Childs, Richard W. ;

Pavletic, Steven Z. ;

Bishop, Michael R. ;

Rader, Christoph .

BLOOD, 2009, 114 (20) :4494-4502

[4] Landscape of somatic mutations and clonal evolution in mantle cell lymphoma [J].

Bea, Silvia ;

Valdes-Mas, Rafael ;

Navarro, Alba ;

Salaverria, Itziar ;

Martin-Garcia, David ;

Jares, Pedro ;

Gine, Eva ;

Pinyol, Magda ;

Royo, Cristina ;

Nadeu, Ferran ;

Conde, Laura ;

Juan, Manel ;

Clot, Guillem ;

Vizan, Pedro ;

Di Croce, Luciano ;

Puente, Diana A. ;

Lopez-Guerra, Monica ;

Moros, Alexandra ;

Roue, Gael ;

Aymerich, Marta ;

Villamor, Neus ;

Colomo, Lluis ;

Martinez, Antonio ;

Valera, Alexandra ;

Martin-Subero, Jose I. ;

Amador, Virginia ;

Hernandez, Luis ;

Rozman, Maria ;

Enjuanes, Anna ;

Forcada, Pilar ;

Muntanola, Ana ;

Hartmann, Elena M. ;

Calasanz, Maria J. ;

Rosenwald, Andreas ;

Ott, German ;

Hernandez-Rivas, Jesus M. ;

Klapper, Wolfram ;

Siebert, Reiner ;

Wiestner, Adrian ;

Wilson, Wyndham H. ;

Colomer, Dolors ;

Lopez-Guillermo, Armando ;

Lopez-Otin, Carlos ;

Puente, Xose S. ;

Campo, Elias .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (45) :18250-18255

[5] Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma [J].

Chiron, David ;

Di Liberto, Maurizio ;

Martin, Peter ;

Huang, Xiangao ;

Sharman, Jeff ;

Blecua, Pedro ;

Mathew, Susan ;

Vijay, Priyanka ;

Eng, Ken ;

Ali, Siraj ;

Johnson, Amy ;

Chang, Betty ;

Ely, Scott ;

Elemento, Olivier ;

Mason, Christopher E. ;

Leonard, John P. ;

Chen-Kiang, Selina .

CANCER DISCOVERY, 2014, 4 (09) :1022-1035

[6] Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies [J].

Dave, Hema ;

Anver, Miriam R. ;

Butcher, Donna O. ;

Brown, Patrick ;

Khan, Javed ;

Wayne, Alan S. ;

Baskar, Sivasubramanian ;

Rader, Christoph .

PLOS ONE, 2012, 7 (12)

[7] Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT) [J].

Dietrich, S. ;

Boumendil, A. ;

Finel, H. ;

Avivi, I. ;

Volin, L. ;

Cornelissen, J. ;

Jarosinska, R. J. ;

Schmid, C. ;

Finke, J. ;

Stevens, W. B. C. ;

Schouten, H. C. ;

Kaufmann, M. ;

Sebban, C. ;

Trneny, M. ;

Kobbe, G. ;

Fornecker, L. M. ;

Schetelig, J. ;

Kanfer, E. ;

Heinicke, T. ;

Pfreundschuh, M. ;

Diez-Martin, J. L. ;

Bordessoule, D. ;

Robinson, S. ;

Dreger, P. .

ANNALS OF ONCOLOGY, 2014, 25 (05) :1053-1058

[8] Incidence and Prognostic Impact of Secondary Cytogenetic Aberrations in a Series of 145 Patients with Mantle Cell Lymphoma [J].

Espinet, Blanca ;

Salaverria, Itziar ;

Bea, Silvia ;

Ruiz-Xiville, Neus ;

Balague, Olga ;

Salido, Marta ;

Costa, Dolors ;

Carreras, Joaquim ;

Eugenia Rodriguez-Vicente, Ana ;

Luis Garcia, Juan ;

Maria Hernandez-Rivas, Jesus ;

Jose Calasanz, Maria ;

Siebert, Reiner ;

Ferrer, Ana ;

Salar, Antonio ;

Carrio, Ana ;

Polo, Natividad ;

Antonio Garcia-Marco, Jose ;

Domingo, Alicia ;

Gonzalez-Barca, Eva ;

Romagosa, Vicenc ;

Marugan, Isabel ;

Lopez-Guillermo, Armando ;

Milla, Fuensanta ;

Luis Mate, Jose ;

Luno, Elisa ;

Sanzo, Carmen ;

Collado, Rosa ;

Oliver, Isabel ;

Monzo, Sebastia ;

Palacin, Antonio ;

Gonzalez, Teresa ;

Sant, Francesc ;

Salinas, Ramon ;

Teresa Ardanaz, Maria ;

Font, Llorenc ;

Escoda, Lourdes ;

Florensa, Lourdes ;

Serrano, Sergi ;

Campo, Elias ;

Sole, Francesc .

GENES CHROMOSOMES & CANCER, 2010, 49 (05) :439-451

[9] Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality [J].

Fenske, Timothy S. ;

Zhang, Mei-Jie ;

Carreras, Jeanette ;

Ayala, Ernesto ;

Burns, Linda J. ;

Cashen, Amanda ;

Costa, Luciano J. ;

Freytes, Cesar O. ;

Gale, Robert P. ;

Hamadani, Mehdi ;

Holmberg, Leona A. ;

Inwards, David J. ;

Lazarus, Hillard M. ;

Maziarz, Richard T. ;

Munker, Reinhold ;

Perales, Miguel-Angel ;

Rizzieri, David A. ;

Schouten, Harry C. ;

Smith, Sonali M. ;

Waller, Edmund K. ;

Wirk, Baldeep M. ;

Laport, Ginna G. ;

Maloney, David G. ;

Montoto, Silvia ;

Hari, Parameswaran N. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04) :273-+

[10] Long-Term Molecular Results Of The Gimema VEL-03-096 Trial: Molecular Remission Achievement and Loss Are Major Outcome Predictors [J].

Ferrero, Simone ;

Ladetto, Marco ;

Drandi, Daniela ;

Cavallo, Federica ;

Genuardi, Elisa ;

Urbano, Marina ;

Guarona, Guglielmo ;

Callea, Vincenzo ;

Cangialosi, Clotilde ;

Caravita, Tommaso ;

Crippa, Claudia ;

De Rosa, Luca ;

Falcone, Antonietta Pia ;

Grasso, Mariella ;

Guglielmelli, Tommasina ;

Liberati, Anna Marina ;

Pisani, Francesco ;

Pregno, Patrizia ;

Rossini, Fausto ;

Oliva, Stefania ;

Rocci, Alberto ;

Passera, Roberto ;

Boccadoro, Mario ;

Palumbo, Antonio .

BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →